T-cell-directed therapies in inflammatory bowel diseases

Giovanni Monteleone, Flavio Caprioli

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Gut inflammation occurring in patients with IBDs (inflammatory bowel diseases) is associated with exaggerated and poorly controlled T-cell-mediated immune responses, which are directed against normal components of the gut flora. T-cells accumulate in the inflamed gut of IBD patients as a result of multiple mechanisms, including enhanced recruitment of cells from the bloodstream, sustained cell cycling and diminished susceptibility of cells to undergo apoptosis. Activated T-cells produce huge amounts of cytokines, which contribute to amplify and sustain the ongoing mucosal inflammation. Strategies aimed at interfering with T-cell accumulation and/or function in the gut have been employed with clinical success in patients with IBDs. In the present article, we review the available results showing that T-cell-directed therapies are useful to dampen the tissue-damaging immune response in IBDs.

Original languageEnglish
Pages (from-to)707-715
Number of pages9
JournalClinical Science
Volume118
Issue number12
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Cell- and Tissue-Based Therapy
Inflammatory Bowel Diseases
T-Lymphocytes
Inflammation
Apoptosis
Cytokines

Keywords

  • Crohn's disease
  • Cytokine
  • Inflammatory bowel disease (IBD)
  • Interleukin
  • T-cell
  • Tumour necrosis factor (TNF)
  • Ulcerative colitis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

T-cell-directed therapies in inflammatory bowel diseases. / Monteleone, Giovanni; Caprioli, Flavio.

In: Clinical Science, Vol. 118, No. 12, 06.2010, p. 707-715.

Research output: Contribution to journalArticle

Monteleone, Giovanni ; Caprioli, Flavio. / T-cell-directed therapies in inflammatory bowel diseases. In: Clinical Science. 2010 ; Vol. 118, No. 12. pp. 707-715.
@article{81473a48cfba461682fe6384492c9a5d,
title = "T-cell-directed therapies in inflammatory bowel diseases",
abstract = "Gut inflammation occurring in patients with IBDs (inflammatory bowel diseases) is associated with exaggerated and poorly controlled T-cell-mediated immune responses, which are directed against normal components of the gut flora. T-cells accumulate in the inflamed gut of IBD patients as a result of multiple mechanisms, including enhanced recruitment of cells from the bloodstream, sustained cell cycling and diminished susceptibility of cells to undergo apoptosis. Activated T-cells produce huge amounts of cytokines, which contribute to amplify and sustain the ongoing mucosal inflammation. Strategies aimed at interfering with T-cell accumulation and/or function in the gut have been employed with clinical success in patients with IBDs. In the present article, we review the available results showing that T-cell-directed therapies are useful to dampen the tissue-damaging immune response in IBDs.",
keywords = "Crohn's disease, Cytokine, Inflammatory bowel disease (IBD), Interleukin, T-cell, Tumour necrosis factor (TNF), Ulcerative colitis",
author = "Giovanni Monteleone and Flavio Caprioli",
year = "2010",
month = "6",
doi = "10.1042/CS20100027",
language = "English",
volume = "118",
pages = "707--715",
journal = "Clinical Science",
issn = "0143-5221",
publisher = "Portland Press Ltd.",
number = "12",

}

TY - JOUR

T1 - T-cell-directed therapies in inflammatory bowel diseases

AU - Monteleone, Giovanni

AU - Caprioli, Flavio

PY - 2010/6

Y1 - 2010/6

N2 - Gut inflammation occurring in patients with IBDs (inflammatory bowel diseases) is associated with exaggerated and poorly controlled T-cell-mediated immune responses, which are directed against normal components of the gut flora. T-cells accumulate in the inflamed gut of IBD patients as a result of multiple mechanisms, including enhanced recruitment of cells from the bloodstream, sustained cell cycling and diminished susceptibility of cells to undergo apoptosis. Activated T-cells produce huge amounts of cytokines, which contribute to amplify and sustain the ongoing mucosal inflammation. Strategies aimed at interfering with T-cell accumulation and/or function in the gut have been employed with clinical success in patients with IBDs. In the present article, we review the available results showing that T-cell-directed therapies are useful to dampen the tissue-damaging immune response in IBDs.

AB - Gut inflammation occurring in patients with IBDs (inflammatory bowel diseases) is associated with exaggerated and poorly controlled T-cell-mediated immune responses, which are directed against normal components of the gut flora. T-cells accumulate in the inflamed gut of IBD patients as a result of multiple mechanisms, including enhanced recruitment of cells from the bloodstream, sustained cell cycling and diminished susceptibility of cells to undergo apoptosis. Activated T-cells produce huge amounts of cytokines, which contribute to amplify and sustain the ongoing mucosal inflammation. Strategies aimed at interfering with T-cell accumulation and/or function in the gut have been employed with clinical success in patients with IBDs. In the present article, we review the available results showing that T-cell-directed therapies are useful to dampen the tissue-damaging immune response in IBDs.

KW - Crohn's disease

KW - Cytokine

KW - Inflammatory bowel disease (IBD)

KW - Interleukin

KW - T-cell

KW - Tumour necrosis factor (TNF)

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=77954082347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954082347&partnerID=8YFLogxK

U2 - 10.1042/CS20100027

DO - 10.1042/CS20100027

M3 - Article

C2 - 20350293

AN - SCOPUS:77954082347

VL - 118

SP - 707

EP - 715

JO - Clinical Science

JF - Clinical Science

SN - 0143-5221

IS - 12

ER -